Background Although venous thromboembolism (VTE) is a recognized side effect of some
formulations of estrogen therapy, its impact in transgender people remains uncertain. The …

As the transgender and gender diverse (TGD) population ages, more transfeminine and
transmasculine individuals present to clinic to initiate or continue their gender-affirming care …

Introduction: Venous thromboembolism (VTE) is a potential risk of estrogen therapy.
However, data show an improvement in the quality of life for transgender people who use …

Abstract Purpose Gender Incongruence (GI) is a marked and persistent incongruence
between an individual's experienced and the assigned gender at birth. In the recent years …

In this article, I argue that adolescent medical transition is ethical by analogizing it to
abortion and birth control. The interventions are similar insofar as they intervene on healthy …

Sexual and gender minority (SGM) people, including agender, asexual, bisexual, gay,
gender diverse, genderqueer, genderfluid, intersex, lesbian, nonbinary, pansexual, queer …

This review discusses the current evidence regarding perioperative hormone therapy for
transgender individuals, with an emphasis on strategies to reduce the risk of perioperative …

Résumé Ces dernières années, la communauté médicale est traversée par les débats
sociétaux autour du genre, du sexe, de la procréation et des droits humains. Aussi les …

The medical care of transgender patients relies on the use of sex hormones to develop and
maintain the physical characteristics consistent with gender identity as the first step in …

Background Transgender women and nonbinary people seeking feminizing therapy are
often prescribed estrogen as a gender-affirming hormone, which will alter their reproductive …